Congenital Adrenal Hyperplasia Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Global Safety and Efficacy Registration Study of Crinecerfont in Pediatric Patients With Classic Congenital Adrenal Hyperplasia (CAHtalyst Pediatric Study)
Condition: Congenital Adrenal Hyperplasia Interventions: Drug: Crinecerfont; Drug: Placebo Sponsor: Neurocrine Biosciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2021 Category: Research Source Type: clinical trials
A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH)
Condition: Congenital Adrenal Hyperplasia Intervention: Biological: BBP-631 Sponsor: Adrenas Therapeutics Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2021 Category: Research Source Type: clinical trials